Judicialization of medicines: effectiveness of rights or break in public policies?

Detalhes bibliográficos
Autor(a) principal: Oliveira,Yonara Monique da Costa
Data de Publicação: 2020
Outros Autores: Braga,Bárbara Suellen Fonseca, Farias,Andrezza Duarte, Pereira,Sylvia Patrícia Dantas, Ferreira,Maria Angela Fernandes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305
Resumo: ABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies.
id USP-23_99e913a95d1ca4e94475307237561280
oai_identifier_str oai:scielo:S0034-89102020000100305
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Judicialization of medicines: effectiveness of rights or break in public policies?Access to Essential Medicines and Health TechnologiesHealth's Judicialization, legislation & jurisprudenceNational Policy of Pharmaceutical AssistanceRight to HealthABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies.Faculdade de Saúde Pública da Universidade de São Paulo2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305Revista de Saúde Pública v.54 2020reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USP10.11606/s1518-8787.2020054002301info:eu-repo/semantics/openAccessOliveira,Yonara Monique da CostaBraga,Bárbara Suellen FonsecaFarias,Andrezza DuartePereira,Sylvia Patrícia DantasFerreira,Maria Angela Fernandeseng2020-12-10T00:00:00Zoai:scielo:S0034-89102020000100305Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=0034-8910&lng=pt&nrm=isoONGhttps://old.scielo.br/oai/scielo-oai.phprevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2020-12-10T00:00Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Judicialization of medicines: effectiveness of rights or break in public policies?
title Judicialization of medicines: effectiveness of rights or break in public policies?
spellingShingle Judicialization of medicines: effectiveness of rights or break in public policies?
Oliveira,Yonara Monique da Costa
Access to Essential Medicines and Health Technologies
Health's Judicialization, legislation & jurisprudence
National Policy of Pharmaceutical Assistance
Right to Health
title_short Judicialization of medicines: effectiveness of rights or break in public policies?
title_full Judicialization of medicines: effectiveness of rights or break in public policies?
title_fullStr Judicialization of medicines: effectiveness of rights or break in public policies?
title_full_unstemmed Judicialization of medicines: effectiveness of rights or break in public policies?
title_sort Judicialization of medicines: effectiveness of rights or break in public policies?
author Oliveira,Yonara Monique da Costa
author_facet Oliveira,Yonara Monique da Costa
Braga,Bárbara Suellen Fonseca
Farias,Andrezza Duarte
Pereira,Sylvia Patrícia Dantas
Ferreira,Maria Angela Fernandes
author_role author
author2 Braga,Bárbara Suellen Fonseca
Farias,Andrezza Duarte
Pereira,Sylvia Patrícia Dantas
Ferreira,Maria Angela Fernandes
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Oliveira,Yonara Monique da Costa
Braga,Bárbara Suellen Fonseca
Farias,Andrezza Duarte
Pereira,Sylvia Patrícia Dantas
Ferreira,Maria Angela Fernandes
dc.subject.por.fl_str_mv Access to Essential Medicines and Health Technologies
Health's Judicialization, legislation & jurisprudence
National Policy of Pharmaceutical Assistance
Right to Health
topic Access to Essential Medicines and Health Technologies
Health's Judicialization, legislation & jurisprudence
National Policy of Pharmaceutical Assistance
Right to Health
description ABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.11606/s1518-8787.2020054002301
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
dc.source.none.fl_str_mv Revista de Saúde Pública v.54 2020
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1748936506097008640